| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/22/2011 | US20110230911 Recombinant spider silk proteins |
| 09/22/2011 | US20110230650 Compositions and Methods for Solubilizing Membrane Proteins Without the Use of Detergent |
| 09/22/2011 | US20110230643 Recombinant flagellin protein and preparation and use thereof |
| 09/22/2011 | US20110230640 Methods for characterizing glycoproteins and generating antibodies for same |
| 09/22/2011 | US20110230639 Immunomodulatory peptides |
| 09/22/2011 | US20110230637 Modified human thymic stromal lymphopoietin |
| 09/22/2011 | US20110230448 Treatment and/or Prevention of Non-Viral Epithelial Damage |
| 09/22/2011 | US20110230422 Purging of an ex vivo hematopoietic stem cell culture of cancer cells |
| 09/22/2011 | US20110230412 Neuregulin Peptides And Their Use |
| 09/22/2011 | US20110230411 Albumin fibers and fabrics and methods of generating and using same |
| 09/22/2011 | US20110230409 GLP-I Agonist And Cardiovascular Complications |
| 09/22/2011 | US20110230405 Peptides and Supported Peptides for Treating Skin Diseases |
| 09/22/2011 | US20110230404 Glycoproteins Produced in Plants and Methods of Their Use |
| 09/22/2011 | US20110230402 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 09/22/2011 | US20110230401 Insulin fusion polypeptides |
| 09/22/2011 | US20110230398 Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders |
| 09/22/2011 | US20110230393 Antibacterial Phage Peptides and Methods of Use thereof |
| 09/22/2011 | US20110230391 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis |
| 09/22/2011 | US20110229982 Method for binding a protein consisting of protein a or consisting of at least one domain of the a to e domains of the protein a to the substrate |
| 09/22/2011 | US20110229964 Fusion Protein Delivery System and Uses Thereof |
| 09/22/2011 | US20110229937 Corynebacterium glutamicum genes encoding regulatory proteins involved in the production of methionine |
| 09/22/2011 | US20110229907 Use of cardiac hormones to assess risk of cardiovascular complication from volume overload |
| 09/22/2011 | US20110229906 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 09/22/2011 | US20110229891 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229523 Modification of allergens for immunotherapy |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229513 LPS Based Vaccines |
| 09/22/2011 | US20110229510 Glycopeptide constructs and uses thereof |
| 09/22/2011 | US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229508 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | US20110229439 Complement proteins |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229433 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 09/22/2011 | US20110226620 Highly Homogeneous Molecular Markers for Electrophoresis |
| 09/22/2011 | CA2793671A1 Bmp-2 peptides & methods of use |
| 09/22/2011 | CA2793169A1 Transformant which produces glycine repeat sequence protein |
| 09/22/2011 | CA2793131A1 Method for modifying the blooming date of a plant |
| 09/22/2011 | CA2793087A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 09/22/2011 | CA2792956A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 09/22/2011 | CA2792413A1 Composition for the anti-cancer metastasis containing dlk1-fc fusion protein as an effective ingredient |
| 09/22/2011 | CA2790183A1 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 09/22/2011 | CA2789647A1 Method for production of polymer containing fibres |
| 09/22/2011 | CA2789615A1 Method for obtaining biologically active recombinant human g-csf |
| 09/22/2011 | CA2789375A1 Novel signal peptide, and use thereof for producing recombinant proteins |
| 09/22/2011 | CA2786940A1 Tumor vaccination involving a humoral immune response against self-proteins |
| 09/21/2011 | EP2367008A2 Modulating the interaction betwenn HGF beta chain and C-Met |
| 09/21/2011 | EP2366791A1 Method for modifying the flowering date of a plant |
| 09/21/2011 | EP2366787A2 Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells |
| 09/21/2011 | EP2366786A2 Cytokine receptor modulators and uses thereof |
| 09/21/2011 | EP2366783A1 Transgenic plants of altered morphology and the isolated arabidopsis thaliana endo-1,4-ß-glucanase gene, promoter and protein |
| 09/21/2011 | EP2366715A2 Rankl Antibody-PTH/PTHRP Chimeric Molecules |
| 09/21/2011 | EP2366712A2 A tumor suppressor designated TS10Q23.3 |
| 09/21/2011 | EP2366711A2 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 09/21/2011 | EP2366710A2 Creating poultry and other animals resistant to viral disease |
| 09/21/2011 | EP2366709A1 Tumor vaccination involving a humoral immune response against self-proteins |
| 09/21/2011 | EP2366708A1 Canine astrovirus AstV strain Bari/08 identified in dogs with gastro-enteritis |
| 09/21/2011 | EP2366707A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 09/21/2011 | EP2366406A1 Method for treating psoriasis |
| 09/21/2011 | EP2366399A1 Non-cytotoxic protein conjugates |
| 09/21/2011 | EP2365985A1 Purification of factor v |
| 09/21/2011 | EP2365984A1 Syndecan-4 is a regulator of rac1-gtp |
| 09/21/2011 | EP2365983A1 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
| 09/21/2011 | EP2365982A1 Peptide synthesis using enzymatic activation and coupling |
| 09/21/2011 | EP2365981A1 Monomeric variants of he tetrameric eqfp611 |
| 09/21/2011 | EP2365822A1 Snake factor v and methods of use as a procoagulant |
| 09/21/2011 | EP2152741B1 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 09/21/2011 | EP2125883B1 Regulatory t cell epitopes, compositions and uses thereof |
| 09/21/2011 | EP2076529B1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 09/21/2011 | EP1829893B1 Immunotherapeutic formulations with interleukin-2-neutralising capacity |
| 09/21/2011 | EP1700096B1 Detection of conformationally altered proteins |
| 09/21/2011 | EP1684793B1 Pharmaceutical composition comprising an insulinotropic glp-1(7-37) analogue, asp(b28)-insulin, and a surfactant |
| 09/21/2011 | EP1651765B8 Novel photobacterium damselae nucleotide and amino acid sequences and uses thereof |
| 09/21/2011 | EP1641823B1 Glp-1 analog fusion plroteins |
| 09/21/2011 | EP1604015B1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS |
| 09/21/2011 | EP1565749B1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 09/21/2011 | EP1549333B1 Compstatin analogues with improved activity |
| 09/21/2011 | EP1507003B1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 09/21/2011 | EP1492811B1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1334178B1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 09/21/2011 | EP1296998B1 Hcv variants |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | EP1263972B1 Methods for homologous recombination |
| 09/21/2011 | EP1180114B1 Use of resisitin specific antibodies in the treatment of diabetes |
| 09/21/2011 | EP1135408B1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/21/2011 | EP1073905B1 Methods of selecting internalizing antibodies |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | EP0871474B2 Generation of human insulin |